Frequently asked questions by pharma product buyers

Frequently asked questions

For buyers

For sellers

Pipelinepharma is a pipeline intelligence and product sourcing platform that connects pharmaceutical companies directly with CTD dossier owners and manufacturers, removing third-party brokerage fees.

A free account allows you to browse products - including generics, innovative assets, biosimilars, medical devices, and nutraceuticals from GMP-certified sites - search for dossiers, apply filters, and view readiness timelines. However, free accounts only display partial information.

To unlock full visibility into product dossiers, access Generic and Biosimilar Pipeline Intelligence, request quotations, compare commercial offers, or start direct communication with manufacturers, users must upgrade to a paid annual subscription. Tiers are priced based on your company’s operational goals and sourcing volume.

Pipelinepharma is the pioneer of Generic and Biosimilar Pipeline Intelligence (Pillar 2). While traditional market databases rely on retrospective sales data or public clinical trials (Pillar 1), we focus on the hidden, pre-launch Common Technical Document (CTD) dossier layer. Having the largest CTD database, our platform tracks the readiness, velocity, and volume of upcoming generic files globally, allowing pharma leaders to eliminate strategic blind spots, protect capital investments, and accurately forecast Day-1 commercial competition.

Our Generic and Biosimilar Pipeline Intelligence protects your capital and accelerates portfolio expansion by providing visibility into the hidden, pre-launch layer of global CTD dossiers. Since your company relies on in-licensing and distribution rather than internal manufacturing or bioequivalence studies, our data supports your commercial workflow across three key areas:

Target Asset Screening: Before shortlisting a new molecule for in-licensing, check the pre-launch dossier density. This ensures you do not invest licensing capital into an overcrowded entry wave ("Red Ocean") where heavy price erosion is inevitable.
Active Account Risk Auditing: Cross-check your current commercialized distribution catalog against global pre-launch dossier volumes to detect hidden competitive waves preparing to enter your local market, giving you time to build defensive market strategies.
White Spot Discovery: Locate absolute product gaps - such as complex fixed-dose combinations with zero active CTD files globally. This provides your team with data-backed opportunities to secure exclusive regional distribution rights with zero hidden competition.

The Annual Subscription includes unlimited browsing of our global CTD dossier database, access to Generic and Biosimilar Pipeline Intelligence, and a pre-agreed volume of direct manufacturer inquiries or standard reports. The fee is billed once a year and does not auto-renew, allowing you to renew manually. Pricing depends entirely on your company's operational scope and sourcing volume requirements.

Pipelinepharma offers flexible, custom pricing tailored to your business needs. The annual fee depends on the size of the product portfolio you want to build, the number of target markets of interest, and the number of user seats required. To get a precise quote tailored to your organization's scope, please contact our team directly for a brief discovery call.

Our experience shows that standard free trials do not fully help companies understand the database depth. Instead, we offer a hands-on, 1-to-2-hour guided session with one of our business development managers. During this session, you will learn how to navigate the platform independently and search for the specific products that interest you.

These practical sessions are scheduled after an initial introductory call, where we map out your company's exact sourcing needs to ensure the hands-on training is highly tailored and productive.

You can register for an introductory video call by contacting our Customer Support Team at [email protected] .

Pharmaceutical companies looking to establish licensing, distribution, technology transfer, or co-development partnerships can utilize our B2B CTD dossier sourcing platform.

While free registration allows product browsing, a paid subscription enables users to see dossier details, submit requests for quotations (RFQs), and connect directly with manufacturers. Subscribing also grants access to our Generic and Biosimilar Pipeline Intelligence tools to identify market white spots, evaluate red or blue oceans, and assist with portfolio planning.

When you submit an inquiry, our platform routes the request to verified manufacturers holding that specific product dossier. You can exclude specific suppliers from receiving your request based on your criteria. To protect confidentiality, initial inquiries are sent anonymously — no company or personal names are disclosed on either side until both sides confirm their interest to start direct discussions.

If you provide the requested company and business case details, you can expect a response within 1 to 15 business days, resulting in one of two outcomes:

Positive Response: You will receive direct connections with one or multiple manufacturers interested in your business case. This includes company names and contact details of the employees responsible for your target markets.
Negative Response: If a manufacturer is not open to pursuing the opportunity, our team will provide that feedback. If the manufacturer shares a reason for the decline, we will include it in our report

Because your request is routed to all manufacturers holding that specific product, there is a high probability you will receive positive feedback from multiple sources. This gives you the freedom to negotiate commercial terms directly with several suppliers and choose the best fit for your needs.

Furthermore, by using our Generic and Biosimilar Pipeline Intelligence data, you can evaluate the broader competitive landscape. This insight allows you to verify if the given offer is fair and competitive, giving you the solid data needed to re-negotiate terms with the supplier.

We use a standardized, industry-specific audit questionnaire where manufacturers provide detailed regulatory and commercial information about the product and dossier. This baseline data is shared with you directly on the platform.

Once both you and the supplier confirm mutual interest in starting direct discussions and executing a confidentiality agreement, it is your responsibility to perform full technical due diligence, conduct the dossier audit, and handle product registration in your target market. In the case of a Marketing Authorization (MA) transfer/sale, the product is already registered, meaning you can conduct your dossier audit and proceed directly to commercializing the asset.

Exclusivity terms are negotiated directly between you and the manufacturer during your commercial discussions. Because Pipelinepharma operates as a commission-free sourcing ecosystem rather than an intermediary, we do not interfere in your deals. Your final exclusivity dynamics remain identical to traditional direct networking.

However, your subscription assists you in catching a manufacturer's attention through several key levers:

Our 13+ Year Reputation: When we route your inquiry, manufacturers recognize Pipelinepharma as an established platform, which helps validate your credibility.
The Multi-Product Bundle: Once connected, you can view the manufacturer's listed portfolio. Sourcing multiple assets allows you to bundle your pipeline, increasing your commercial leverage and making your business case more practical for them.

Ultimately, you differentiate your organization by presenting a complete company profile, a reasonable business case, and responsive communication, while the power to negotiate exclusivity remains entirely in your hands.

Manufacturers receive many inquiries, and providing this dataset helps introduce your organization as a practical partner. Each data point serves a specific purpose in securing a response:

Company Data: Allows the manufacturer to evaluate your candidacy for a potential partnership.
Annual Purchase Forecast: You asked to provide a preliminary annual purchase volume forecast for year 1, year 2, and ideally year 3, alongside the specific pharmaceutical form, strength, and pack size. This allows the manufacturer to estimate the business case size and ensure it meets their Minimum Order Quantity (MOQ). Crucially, Pipelinepharma does not disclose your forecast alongside your company name - confidentiality is maintained until both sides confirm mutual interest to start direct discussions.
Market Data: Sharing local market price levels helps the manufacturer evaluate production feasibility and determine if they can provide an offer that aligns with your local market.

Ultimately, providing thorough information helps you receive a commercial offer or feedback if the business case cannot be implemented.

Yes, Pipelinepharma offers a Premium sourcing service for buyers. It is a paid service provided by our Business Development and Licensing team. Premium sourcing covers custom services like:

Product sourcing on behalf of a buyer in extensive supplier databases
Searching for defined product suppliers
Searching for differentiated or complex products
Searching for technology transfer or CMO change
Product co-development.

Premium sourcing is priced on a case-by-case basis. For more information. please contact us.

Frequently asked questions

Want to get industry news?